Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Legal, PR Efforts Ramp Up To Target J&J On Vaginal Mesh Device Issues

This article was originally published in The Gray Sheet

Executive Summary

The Corporate Action Network has launched a new website intended to shame the firm for practices tied to its withdrawn pelvic mesh implant devices, while requesting a Department of Justice investigation into the firm’s document-destruction activities and hatching plans to disrupt J&J’s annual shareholder meeting.

You may also be interested in...



J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

Janssen subsidiary pleads guilty as part of $2.2 billion deal that also requires audits of sales rep compensation.

J&J/Ethicon Begins Worldwide Withdrawal Of Vaginal Mesh Products

Firm is stopping sales of four of its vaginal mesh products in the face of over 1,000 product liability lawsuits and FDA requirements for post-market safety and efficacy studies.

Coronavirus Update: Moderna’s Vaccine Shows Signs Of Lasting Protection

The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals starts a Phase I trial of a DHODH inhibitor.

Topics

UsernamePublicRestriction

Register

OM002409

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel